-
公开(公告)号:US20220288185A1
公开(公告)日:2022-09-15
申请号:US17632943
申请日:2020-08-10
申请人: Valneva SE
摘要: The present invention is related to novel liquid and lyophilized formulations of Chikungunya virus useful as vaccines and methods for their preparation.
-
公开(公告)号:US11207397B2
公开(公告)日:2021-12-28
申请号:US16702764
申请日:2019-12-04
申请人: Valneva SE
摘要: Described herein are improved purification methods for virus vaccines and compositions. Also described are Zika, Chikungunya, dengue and yellow fever vaccines and methods of producing and administering said vaccines to subjects in need thereof.
-
公开(公告)号:US11357846B2
公开(公告)日:2022-06-14
申请号:US17407499
申请日:2021-08-20
申请人: Valneva SE
发明人: Andrea Fritzer , Andreas Meinke , Urban Lundberg , Mario Nebenführ , Jürgen Heindl-Wruss , Robert Schiegl , Arnaud Leon
摘要: The present invention relates to a process for producing an immunogenic live attenuated Chikungunya virus, as well as pharmaceutical compositions comprising the same.
-
公开(公告)号:US20200368342A1
公开(公告)日:2020-11-26
申请号:US16840760
申请日:2020-04-06
申请人: Valneva SE
摘要: Described herein are processes for purifying infectious virus particles and uses of protamine in such processes.
-
公开(公告)号:US10537630B2
公开(公告)日:2020-01-21
申请号:US16062245
申请日:2016-12-23
申请人: Valneva SE
摘要: Described herein are improved purification methods for virus vaccines and compositions. Also described are Zika, Chikungunya, dengue and yellow fever vaccines and methods of producing and administering said vaccines to subjects in need thereof.
-
公开(公告)号:US20220016230A1
公开(公告)日:2022-01-20
申请号:US17407499
申请日:2021-08-20
申请人: Valneva SE
发明人: Andrea Fritzer , Andreas Meinke , Urban Lundberg , Mario Nebenführ , Jürgen Heindl-Wruss , Robert Schlegl , Arnaud Leon
摘要: The present invention relates to a process for producing an immunogenic live attenuated Chikungunya virus, as well as pharmaceutical compositions comprising the same.
-
公开(公告)号:US12011477B2
公开(公告)日:2024-06-18
申请号:US17935490
申请日:2022-09-26
申请人: Valneva SE
发明人: Andrea Fritzer , Andreas Meinke , Urban Lundberg , Mario Nebenführ , Jürgen Heindl-Wruss , Robert Schlegl , Arnaud Leon
CPC分类号: A61K39/12 , A61K9/0019 , A61K9/19 , A61P31/14 , C07K14/005 , C12N7/00 , A61K2039/5254 , A61K2039/54 , C12N2770/36121 , C12N2770/36122 , C12N2770/36123 , C12N2770/36134
摘要: The present invention relates to a process for producing an immunogenic live attenuated Chikungunya virus, as well as pharmaceutical compositions comprising the same.
-
公开(公告)号:US11406700B2
公开(公告)日:2022-08-09
申请号:US16840760
申请日:2020-04-06
申请人: Valneva SE
摘要: Described herein are processes for purifying infectious virus particles and uses of protamine in such processes.
-
公开(公告)号:US10660950B2
公开(公告)日:2020-05-26
申请号:US15781959
申请日:2016-12-23
申请人: Valneva SE
摘要: Described herein are processes for purifying infectious virus particles and uses of protamine in such processes.
-
-
-
-
-
-
-
-